Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 5.43
+0.27 (5.23%)
At close: Dec 19, 2025
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 9.8 billion as of December 19, 2025. Its market cap has increased by 98.19% in one year.
Market Cap
9.80B
Enterprise Value
10.18B
Revenue
767.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.43
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 9.80B, a decrease of -17.26%. That is a compound annual growth rate of -4.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 9.80B | 118.62% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 263.64B |
| Hansoh Pharmaceutical Group Company | 235.74B |
| JD Health International | 182.96B |
| Innovent Biologics | 138.39B |
| WuXi Biologics | 134.33B |
| Sino Biopharmaceutical | 115.13B |
| Akeso | 107.68B |
| Sichuan Kelun-Biotech Biopharmaceutical | 94.81B |